Stock Market

With the 2023 NFL season set for kick-off, keep an eye on sports gambling stocks. As DraftKings’ CEO Jason Robins recently noted, “It’s about to be the most important time of year seasonally for us. We have fall coming up with the NFL, the college football calendar and the NBA. This is when we acquire

Insider stock purchases are notable because they signal confidence in the company. So, investors should pay attention if an executive at Intel (NASDAQ:INTC) made a large-scale share purchase. This, along with Intel’s ambitious sales outlook, are reasons to consider INTC stock now. As we’ll see, Intel’s most recently released quarterly results weren’t perfect. There are notable

C3.AI (NYSE:AI) stock had revenue of $72.4 million for the quarter ending in April. A year earlier, before the AI hullaballoo began, sales were $72.3 million. Losses have been averaging $60 million per quarter. Almost as much money gets lost as comes in. It’s a poor man’s Palantir (NASDAQ:PLTR). Investors are now paying $33 per

The narrative around the strength of the consumer economy is, simply put, nonsense. The reality painted by retail stocks, particularly the SPDR S&P Retail ETF (NYSEARCA:XRT), is quite different. Does this look like a chart that is in a “new bull market?” Man – that new bull market in retailers is really something. $XRT pic.twitter.com/c9baCY2Prc

Meta Platforms (NASDAQ:META) stock has surged 150% in 2023. But most of the gain isn’t based on reality. Instead, Meta has gone from being one of the most-hated stocks on Wall Street to one of the most loved, thanks to artificial intelligence. At the start of 2023, Meta stock was bouncing around the 120s. It

Certain stocks have surged this year, with hyper-growth tech companies seeing some of the biggest gains. The three companies listed below have highlighted what momentum can mean for sustained moves higher, even though these stocks are all down at least 10% from their all-time highs, at the time of writing.  Many investors question whether this

Recent industry and macro factors caused Nvidia (NASDAQ:NVDA) stock to dip, sparking concerns about its 2023 rally. Despite a slight decline, don’t dismiss the ongoing generative AI mega trend driving its powerful performance.  That said, investors should recognize the limits of Nvidia’s growth potential despite the market’s enthusiasm for AI. While NVDA benefits from AI

Li Auto (NASDAQ:LI) stock saw profit taking after reporting record earnings for the June quarter. Li earned $300 million, 30 cents per ADR share fully diluted, on revenue of $3.95 billion during the quarter. Deliveries more than tripled from a year ago, to 86,533 vehicles. Despite this, shares hit an air pocket, falling from $46.63

SoFi Technologies (NASDAQ:SOFI) is a banking sector disruptor that’s garnered a lot of attention on Wall Street. Opinions vary, but one notable theme among analysts is that SOFI stock looks overvalued. I tend to agree, and while I like SoFi Technologies as a company, I recommend that prospective investors wait for the share price to come

As the EV landscape shifts, investors considering Lucid Group (NASDAQ:LCID) stock for its recent strong performance have been rewarded. Momentum has taken LCID stock on a bumpy, but upward ride this year. And while Lucid has seen its valuation come down from its peak in Q1, there are reasons some investors remain very bullish on

Shares of Massachusetts-based T2 Biosystems (NASDAQ:TTOO) surged another 30% this week on meme stock interest. According to financial data provider Fintel.io, retail ownership has now risen over six-fold since last month. In a sense, T2’s rapid ascent comes as no surprise. Shares of the highly shorted healthcare firm have risen 110% since the start of

Bloom Energy (NYSE:BE) stock is puzzling. Th company continues to grow its hydrogen fuel cell business but it has yet to see a profit. The second quarter report is typical. Bloom announced on Aug. 3 that second quarter sales were up nearly 24%, compared to the same quarter a year ago. But there was still

In 2014, Massachusetts-based T2 Biosystems (NASDAQ:TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion industry, and T2’s Magnetic Resonance Platform (T2MR) was potentially game-changing. Shares would quickly rise to a pre-split $23. The product, however, would prove a dud. In 2020, most of

While Upstart (NASDAQ:UPST) focuses on artificial intelligence in 2023, the company isn’t just jumping on the AI bandwagon. UPST stock earns a solid “B” grade because Upstart is deploying its technology in a useful and interesting way. Financial traders should weigh their tolerance for risk before considering an investment in Upstart. What Upstart seeks to achieve

Investors should expect a steep selloff among artificial intelligence stocks, as Wall Street cashes in on the high valuations many companies in this sector provide. On the other hand, some high-potential AI names remain overlooked, and the recent AI craze has done little to uplift their valuation. Thus, as the rally cools, smart investors will

The biotech industry proved itself resilient in the face of the COVID-19 pandemic. With research from Mckinsey, venture capitalist (VC) companies increased investments from 2,200 in 2016 to 3,100 in 2021 in biotechnology (biotech) startups. These startups have advanced medicine overall, improving cell therapy, tissue regeneration, genetic medicine, and more. With increasing innovation, we see

It’s worth noting that blue-chip stocks go through their own bull and bear phase. Nvidia (NASDAQ:NVDA) was under-performing until October 2022. The massive rally in the last three quarters has more than compensated for the bear phase. With strong fundamentals, several other undervalued blue-chip stocks are worth considering for the long-term even as the markets

Last week, meme investors “discovered” Rite Aid (NYSE:RAD), sending its shares up 70%. The Wall Street Journal would quickly give the company a meme stock crown. For most traditional investors, Rite Aid looks like a terrible bet. The struggling drug retailer hasn’t been profitable since 2017, and a deal five years ago to sell 1,932

Rivian Automotive (NASDAQ:RIVN) shareholders are certainly reaping the rewards of this bull market in the EV sector. Indeed, shares of the EV manufacturer recently surged nearly 90% over just nine sessions. While RIVN stock has since given up some of these gains, it still has almost doubled from its $13.45 level on June 26. Investors

Amid market volatility, enduring investments are hard to find. However, a few resilient, innovative blue-chip stocks offer competitive prices and total returns over the long term. The first stock, fueled by AI and loyalty achievements, thrives internationally. Digital innovation and strategic initiatives underpin its growth, with global expansion yielding remarkable results, especially in China. With